Groechel Renee C, Liu Albert C, Koton Silvia, Kucharska-Newton Anna M, Lutsey Pamela L, Mosley Thomas H, Palta Priya, Sharrett A Richey, Walker Keenan A, Wong Dean F, Gottesman Rebecca F
National Institute of Neurological Disorders and Stroke Intramural Research Program, National Institutes of Health, Bethesda, MD, USA.
Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA.
J Alzheimers Dis. 2024;97(4):1901-1911. doi: 10.3233/JAD-231218.
Psychosocial factors are modifiable risk factors for Alzheimer's disease (AD). One mechanism linking psychosocial factors to AD risk may be through biological measures of brain amyloid; however, this association has not been widely studied.
To determine if mid-life measures of social support and social isolation in the Atherosclerosis Risk in Communities (ARIC) Study cohort are associated with late life brain amyloid burden, measured using florbetapir positron emission tomography (PET).
Measures of social support and social isolation were assessed in ARIC participants (visit 2: 1990-1992). Brain amyloid was evaluated with florbetapir PET standardized uptake value ratios (SUVRs; visit 5: 2012-2014).
Among 316 participants without dementia, participants with intermediate (odds ratio (OR), 0.47; 95% CI, 0.25-0.88), or low social support (OR, 0.43; 95% CI, 0.22-0.83) in mid-life were less likely to have elevated amyloid SUVRs, relative to participants with high social support. Participants with moderate risk for social isolation in mid-life (OR, 0.32; 95% CI, 0.14-0.74) were less likely to have elevated amyloid burden than participants at low risk for social isolation. These associations were not significantly modified by sex or race.
Lower social support and moderate risk of social isolation in mid-life were associated with lower odds of elevated amyloid SUVR in late life, compared to participants with greater mid-life psychosocial measures. Future longitudinal studies evaluating mid-life psychosocial factors, in relation to brain amyloid as well as other health outcomes, will strengthen our understanding of the role of these factors throughout the lifetime.
社会心理因素是阿尔茨海默病(AD)的可改变风险因素。将社会心理因素与AD风险联系起来的一种机制可能是通过大脑淀粉样蛋白的生物学测量;然而,这种关联尚未得到广泛研究。
确定社区动脉粥样硬化风险(ARIC)研究队列中中年时期的社会支持和社会隔离测量指标是否与使用氟代硼吡葡萄糖正电子发射断层扫描(PET)测量的晚年大脑淀粉样蛋白负担相关。
在ARIC参与者中评估社会支持和社会隔离测量指标(访视2:1990 - 1992年)。使用氟代硼吡葡萄糖PET标准化摄取值比率(SUVRs;访视5:2012 - 2014年)评估大脑淀粉样蛋白。
在316名无痴呆症的参与者中,与社会支持高的参与者相比,中年时期社会支持处于中等水平(比值比(OR),0.47;95%置信区间(CI),0.25 - 0.88)或低水平(OR,0.43;95% CI,0.22 - 0.83)的参与者淀粉样蛋白SUVR升高的可能性较小。中年时期社会隔离风险中等的参与者(OR,0.32;95% CI,0.14 - 0.74)比社会隔离风险低的参与者淀粉样蛋白负担升高的可能性更小。这些关联未因性别或种族而有显著改变。
与中年社会心理测量指标更高的参与者相比,中年时期较低的社会支持和中等的社会隔离风险与晚年淀粉样蛋白SUVR升高几率较低相关。未来评估中年社会心理因素与大脑淀粉样蛋白以及其他健康结局关系的纵向研究,将加强我们对这些因素在整个生命周期中作用的理解。